Clinical Evaluation of the Efficacy of Trayodashanga Guggulu, Maharasnadi Kwatha and Prasarani Taila in the Management of Gridhrasi (Sciatica)

Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 53 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients of either sex within the age between 18-65 years.
•2.Low back pain radiating to one or both lower extremities (buttock and below) of >3 months but equal or less than 2 years duration.
•3.Patient testing positive for Straight Leg Raising (SLR), Lasegueâ??s sign
•4.Patients with a pain level of equal or greater than 2 on a scale of 0-10 (VAS)
•5.MRI evidence of a herniated disc spine corresponding to the patientâ??s radicular symptoms.
•6.Willing to participate in the study.

•1.Tuberculosis of the spine / hip.
•2.Ankylosing spondylosis or Fractures or secondary to fractures
•3.Patients with neurological deficits like, sensory loss, foot drop, limb muscle wasting and bowel/bladder incontinence
•4.Patients diagnosed as diabetes mellitus (HbA1c > 6.5 %, FBS >126 mg/dl) and complications of Diabetes Mellitus viz., neuropathy, nephropathy, retinopathy, etc.
•5.Patients who have a known history of cardiovascular diseases.
•6.Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl), uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease.
•7.Inflammatory Bowel Disease, Severe Dementia, Severe Infection(s), Non-ambulatory patients Monoplegia / Paraplegia/hemiplegia.
•8.Pregnant / Lactating women.
•9.Patients with evidence of malignancy
•10.Psychiatric diseases, Alcoholics and/or substance abusers
•11.Patients who have completed participation in any other clinical trial during the past six (06) months.
•12.Any other condition which the Investigator thinks may jeopardize the study.

发起方

Central Council for Research in Ayurvedic Sciences CCRAS